Skip to content

Drug interactions

Infliximab + Vedolizumab

Severity: Moderate

Infliximab and Vedolizumab: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Vedolizumab is gut-selective, but combining it with a TNF blocker may increase infection risk and is not recommended in labeling. Combination use has been explored in refractory inflammatory bowel disease with specialist oversight.

What this interaction means in plain words

Infliximab and Vedolizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Infliximab belongs to Musculoskeletal; Vedolizumab belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Additive immunosuppression from systemic TNF-alpha blockade and gut-selective alpha4beta7 integrin inhibition.

What to do

Avoid routine combination; if used in refractory disease, monitor for infection closely.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Infliximab and Vedolizumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Infliximab with Vedolizumab?

MediHelp rates the interaction as moderate. Infliximab and Vedolizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Vedolizumab is gut-selective, but combining it with a TNF blocker may increase infection risk and is not recommended in labeling. Combination use has been explored in refractory inflammatory bowel disease with specialist oversight.

How serious is the interaction between Infliximab and Vedolizumab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid routine combination; if used in refractory disease, monitor for infection closely.

What other medicines interact with Infliximab?

MediHelp also lists interactions of Infliximab with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine. The full list is on the Infliximab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in